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Abstract 
Hepatitis E infection is usually a self-limiting disease. In industrialized countries, sporadic cases of acute hepatitis E virus (HEV) infections 
have been described; their number seems to be increasing in European countries. We report the first human case of autochthonous acute 
hepatitis E confirmed in Portugal. Patients with acute non-A-C hepatitis should be tested for HEV in Portugal and hepatitis E infection should 
be considered in the differential diagnosis of unexplained hepatitis cases. 
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Introduction 
Autochthonous, sporadic cases of hepatitis E 
have been reported in various countries from Europe 
and North America, including the United Kingdom, 
France, Italy, Spain, the Netherlands, Greece, 
Hungary, Germany, Austria, Poland, and in various 
regions from the USA. Most of these human cases are 
due to HEV genotype 3 which is common in swine 
livestock and is considered a zoonosis of porcine 
origin.  
Transmission to humans may occur through the 
consumption of raw or poorly cooked meat. The 
majority of patients present during early winter and 
summer [1].  
 
Case report 
In November 2010, a 65-year-old male patient 
was referred to our hospital and admitted to the 
infectious disease service on 16 November 2010, 
with a provisional diagnosis of acute hepatitis. Six 
days prior to the admission, the patient presented a 
progressive onset of a fever, fatigue, loss of appetite, 
upper abdominal discomfort and dark-coloured urine 
noticed in the day of referral. 
Laboratory results revealed elevated serum liver 
enzymes with a total bilirubin level of 6 mg/dL. 
Direct bilirubin level was 3.9 mg/dL, serum aspartate 
aminotransferase (AST) concentration was 1458 U/L, 
alanine aminotransferase (ALT) was 2232 U/L, 
alkaline phosphatase (AP) was 196 U/L and GGT 
was 524 U/L. Thrombocytopenia (112,000/mm3) was 
observed. The peak of liver enzymes was observed 
on the tenth day after the start of the clinical 
manifestations and returned to normal values on day 
25. The platelet count dropped to 90,000/mm3 and 
returned to normal values on day 17 after the start of 
the clinical manifestations. 
C-reactive protein values were slightly elevated 
and reached 2.07 mg/dL and rapidly normalized. 
Hepatitis types A to C were excluded by 
serological and molecular tests. Acute infection with 
herpesviruses, parvovirus B19, syphilis, Q-fever, 
brucella, HIV-1/2 and Leptospira interrogans were 
also excluded.  
Anti-hepatitis E virus IgM and IgG were positive 
in ELISA (HEV IgM ELISA 3.0 and HEV ELISA, 
MP Biomedicals, Singapore) in a blood sample taken 
10 days after the start of the clinical manifestations.  
Four additional blood samples were collected from 
the patient, and all were positive for IgM and IgG 
antibodies against hepatitis E. No liver biopsy or 
molecular studies were performed for hepatitis E 
virus.  
Electrocardiogram showed an atrial flutter. 
Echocardiography showed a good left and right 
ventricular pump function without any evidence for 
liver congestion due to chronic right-sided heart 
failure.  
Abdominal ultrasound showed a slight 
hepatomegaly without splenomegaly.  
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The patient’s medical history included insulin 
controlled type 2 diabetes mellitus and cardiac 
arrhythmia. 
The patient’s medication included long-acting 
insulin and anticoagulation with warfarin. No history 
of alcohol consumption or drug-induced 
hepatotoxicity was observed. 
He resided in an urban area. There was no 
travelling history in the last six months; contact with 
animals, as well consumption of raw meat and 
contact with water or sewage were denied. The 
patient had no past history of drug addiction or 
sexually transmitted diseases. However, he recalled 
to have eaten traditional homemade pork sausages 
made of raw meat about two weeks prior to the 
development of the clinical manifestations of acute 
hepatitis. The patient was admitted to the infectious 
diseases ward on 16 November and was discharged 
on 3 December 2010. He started feeling better over 
the first week of hospitalization and was discharged 
asymptomatic. He was observed once at the 
outpatient’s clinic on the 23 March 2011, and was 




The clinical features of autochthonous hepatitis E 
range from asymptomatic infection to mild hepatitis 
or subacute liver failure. Hepatitis E infection in most 
individuals manifests as a self-limiting, acute, icteric 
hepatitis. The presentation seems to be similar to that 
from endemic regions; however, the mortality rate is 
higher, ranging from 8% to 11% associated with 
fulminant hepatitis and liver failure [2].Icterus was 
described as occurring in 75% of the affected 
individuals [3]. 
The incubation period of autochthonous hepatitis 
E varies from two to nine weeks. The concentration 
of serum liver enzymes, with a predominant 
transaminitis, peaks at about six weeks post exposure 
before falling to normal levels by week 10. The rise 
in serum transaminases and bilirubin usually peaks at 
presentation except in the few individuals who go on 
to develop liver failure. 
The outcome can be poor in individuals with 
underlying chronic liver disease, with mortality close 
to 70% [4,5]. 
A chronic hepatitis E infection has been 
documented in patients receiving immunossupressive 
therapy following organ transplantation [6]. 
HEV RNA is cleared from the blood a few days 
to weeks after the onset of clinical symptoms; 
however, the virus continues to be shed in stools for 
another two weeks [7]. 
In the developed world most autochthonous 
hepatitis E infections are reported in middle-aged and 
elderly man [2]. 
HEV is comprised of at least five genotypes: 
genotypes 1 and 2 are strictly human; genotypes 3 
and 4 are probably of swine origin but infect humans; 
genotype 5 is of avian origin and probably does not 
infect humans [7]. HEV genotypes 3 and 4, which 
infect both humans and swine, have been recovered 
from pigs in regions that roughly parallel the 
distribution of these viruses in human infections. It is 
likely that HEV infections are acquired from an 
animal reservoir, such as swine. There is support for 
a zoonotic source of HEV infection in industrialized 
countries either through occupational exposure to 
pigs, as happens in veterinarians and pig industry 
workers, or through the consumption of uncooked or 
poorly cooked pig, wild boar and deer meat [8]. 
Widespread infection has been demonstrated in pigs, 
with more than 90% of farms infected in Spain at 
least since 1980 [9]. 
In areas of southwest France where the incidence 
of hepatitis E is stable, 97% of the cases are 
autochthonous and occur predominantly in males. 
Genotype 3 is most commonly found in humans and 
is closely related to the swine strains isolated in Spain 
and France [10,11]. However, in these countries, the 
main routes of transmission have yet to be 
established.  
The routine laboratory diagnosis of hepatitis E 
depends on serology and nucleic acid amplification 
techniques. Antibody response to hepatitis E 
infection follows a conventional course with specific 
IgM antibodies usually detectable at the onset of the 
symptoms persisting for an average of three months 
and IgG reaches a peak shortly after and can be 
detected for at least 12 years after acute infection. 
Real-time RT-PCR assays have been used to 
detect HEV RNA in clinical specimens and seem to 
be more sensitive than serology; however, the 
window of detectable viraemia is narrow (range 17-
48 days). 
In our case the first blood sample was collected 
on 19 November (three days after hospital admission 
and nine days after clinical manifestations started). 
Four additional blood samples were collected from 
the patient (3 and 15 December 2010, and 11 January 
and 23 March 2011), and all were positive for IgM 
and IgG antibodies against hepatitis E. No molecular 
studies were performed for hepatitis E virus because 
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they are not currently performed at the Portuguese 
National Institute of Health. 
The diagnosis of acute hepatitis E infection rests 
on the demonstrations of specific IgM, rising levels 
of IgG, or detection of HEV RNA [2]. 
Hepatitis E is still regarded by many health care 
professionals as a travel-associated disease. Thus a 
considerable amount of autochthonous infections 
associated with acute hepatitis may remain 
undiagnosed. There is no data available on incidence 
of hepatitis E in Portugal. However, published data 
showed a seroprevalence of 2.5% for Hepatitis E in 
Portuguese blood donors [12]. 
In conclusion, patients with acute non-A-C 
hepatitis should be tested for HEV in Portugal and 
hepatitis E infection should be considered in the 
differential diagnosis of unexplained hepatitis cases. 
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